ogarawo.wordpress.com
Government regulators granted accelerated approva for Avastin for people with glioblastoma who have experienced a progressioh of the disease followingpriore treatment. Glioblastoma affects 10,000 people per year Glioblastoma tumors nearly always returnn followinginitial treatment. Dr. Lisa Fichtel, a medicao oncologist and hematologist with the START Center for Cancer Care in San says she has witnessed firstr hand how this drug has helped patienta withbrain cancer. “This is the firsrt new treatment in more than 10 yearsa for people with this type of aggressivbrain cancer,” Fichtel says.
Fichtel sees at leastf one new brain cancer patient each week and has seen the positived impact this drug has had in not only slowing the progressionb of the disease but also improving the quality of life of patientsz inSan Antonio. Genentech gained FDA approval after concluding an open-label, multicenter, non-comparativr Phase II study of 167 patients with glioblastoma. The Southb San Francisco-based biotechnology company worksto discover, manufacture and commercialize medicines that treat patientds with serious or life-threatening medical provides oncology research and treatment.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment